A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away. Earlier studies have suggested that people and animals given the widely used pill for type-2 diabetes, called pioglitazone, were less likely to develop Alzheimer's or other forms of dementia. They tracked a database of about 146,000 patients age 60 and older who initially did not have evidence of dementia. The analysis showed that 13,841 subjects eventually developed dementia, and that for those taking pioglitazone the risk of dementia was significantly reduced with each additional three months the drug was prescribed. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment